Abstract:Objective:Radiotherapy is one of the standard treatments for pelvic malignant tumors. However, researches associated with intestinal radiation injury and the quality of life (QoL) of patients receiving radiotherapy were lacking in the past. This study aims to analyze the occurrence of radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors and call for more attention on this issne.Methods:A retrospectively observational study was conducted. Case data of cervical cancer patients from the database of STARS phase 3 randomized clinical trial (NCT00806117) in Sun Yat-sen University Cancer Center were analyzed. A total of 848 cervical cancer patients who received adjuvant radiation following hysterectomy and pelvic lymphadenectomy in Sun Yat-sen University Cancer Center from February 2008 to August 2015 were recruited. The pelvic radiation dosage was 1.8 Gy/day or 2.0 Gy/day, five times every week, and the total dosage was 40-50 Gy. Among 848 patients, 563 patients received radiation six weeks after surgery, of whom 282 received adjuvant radiation alone and 281 received concurrent chemoradiotherapy (weekly cisplatin); other 285 patients received sequential chemoradiotherapy (paclitaxel and cisplatin). Acute adverse events, chronic radiation damage of rectum, and QoL were collected and analyed. The digestive tract symptoms and QoL were evaluated based on EORTC QLQ-C30 questionnaires at one week after surgery (M0), during adjuvant therapy period (M1), and at 12 months and 24 months after the completion of treatments (M12 and M24), respectively. Higher scores in the functional catalog and overall quality of life indicated better quality of life, while higher scores in the symptom catalog indicated severe symptoms and worse QoL. Chronic radiation rectal injury was defined as digestive symptoms that were not improved within three months after radiotherapy. Grading standard of acute adverse events and chronic radiation rectal injury was according to the gastrointestinal part of National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0 (NCI-CTCAE Version 4.0).Results:The mean total radiation dosage of 848 patients was (47.8±4.6) Gy. During adjuvant therapy, the common symptoms of acute intestinal dysfunction were nausea (46.0%, 390/848), vomiting (33.8%, 287/848), constipation (16.3%, 138/848) and abdominal pain (10.3%, 87/848). At M12 and M24, the number of 0 QLQ-C30 questionnaires collected was 346 and 250, respectively. QLQ-C30 questionnaires showed that the scores of nausea or vomiting, appetite decrease, diarrhea, constipation, etc. were improved obviously at M12 or M24 compared with those at M0 or during M1 (all P<0.05). As the extension of the follow-up time, the score of the overall QoL of patients gradually increased [M0: 59.7 (0.0-100.0); M1: 63.1 (0.0-100.0); M12: 75.2 (0.0-100.0); M24: 94.1 (20.0-120.0); H=253.800, P<0.001]. Twelve months after the completion of treatments, the incidence of chronic radiation rectal injury was 9.8% (34/346), mainly presenting as abdominal pain, constipation, stool blood, diarrhea, mostly at level 1 to 2 toxicity (33/34, 97.1%). One patient (0.3%) developed frequent diarrhea (>8 times/d), which was level 3 toxicity. Twenty-four months after all treatments, the incidence of chronic radiation rectal injury was 9.6% (24/250), which was not decreased significantly compared to that in the previous period (χ 2=0.008, P=0.927). The symotoms of one patient with level 3 toxicity was not relieved. Conclusions:The common symptoms of patients with pelvic maligant tumors during postoperative adjuvant radiotherapy include nausea, vomiting, constipation, abdominal pain and diarrhea. These symptoms are alleviated obviously at 12 and 24 months after adjuvant radiotherapy, and the QoL is significantly improved. However, a few patients may develop chronic radiation rectal injury which is not improved for years or even decades, and deserves attention in clinical practice.

Clinical Observation of Radiation Urinary Bladder Disease

Bladder fullness and its influencing factors in patients undergoing radiotherapy: an analysis based on image reconstruction

Diagnosis and Treatment of Hemorrhagic Irradiation Cystitis with Spontaneous Rupture of Bladder

Urodynamic Evaluation for Patients with Voiding Dysfunction Secondary to Pelvic Neoplasm Radiotherapy

Clinical Guidelines for the Prevention and Treatment of Radiation‐induced Bladder Injury

Peritoneal Bladder Fistula Following Radiotherapy for Cervical Cancer: A Case Report.

Diagnosis and treatment of radiation proctitis analysis of 97 cases

Radiotherapy of 53 Patients with Bladder Cancer

Current status of diagnosis and treatment of bladder cancer in China – Analyses of Chinese Bladder Cancer Consortium database

Current management of radiation cystitis after pelvic radiotherapy: a systematic review

Label-free Observation of Morphological Alteration of Irradiated-Urothelial Bladder Carcinoma Cells Through Digital Holographic Microscopy

Insights from RNA Sequencing

Irradiation dose of bladder in 60Co radiotherapy course

Treatment and Diagnosis of No Macrohematuria Bladder Cancer: Report of 19 Cases

Efficacy of Hyperbaric Oxygen Combined with Transurethral Bladder Electrocoagulation in the Treatment of Radiation Cystitis Hematuria

Clinical Observation on Radiotherapy Combined with Chinese Medicine Enema for 47 Cases of Radiation Enteritis

Urinary diversions after radiation for prostate cancer: indications and treatment

Chronic Radiation-Induced Rectal Injury after Adjuvant Radiotherapy for Pelvic Malignant Tumors: Report Based on a Phase 3 Randomized Clinical Trial

The Significance of Portable Bladder Scanner in Radiotherapy for Locally Advanced Cervical Cancer Patients

Economic Burden Associated with Hospitalization for Radiation Cystitis: Results from a Statewide Inpatient Database

Effect of Bladder Volume on Radiation Doses to Organs at Risk and Tumor in Cervical Cancer During Image-Guided Adaptive Brachytherapy and Treatment Outcome Analysis